questionsmedicales.fr
Cellules
Cellules épithéliales
Cellules endothéliales
Cellules endothéliales : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dysfonction endothéliale
Échographie Doppler
Protéine C-réactive
Cytokines
Angiographie
Imagerie par résonance magnétique
Symptômes
5
Dysfonction endothéliale
Œdème
Athérosclérose
Essoufflement
Thrombose veineuse
Douleur
Prévention
5
Mode de vie sain
Alimentation équilibrée
Tabagisme
Aliments anti-inflammatoires
Cholestérol
Activité physique
Diabète
Graisses saturées
Traitements
5
Statines
Changements de mode de vie
Anti-inflammatoires
Corticostéroïdes
Anticoagulants
Antiplaquettaires
Ischémie chronique
Chirurgie
Complications
5
Maladies cardiovasculaires
AVC
Thrombose
Maladies auto-immunes
Crise cardiaque
Douleurs angineuses
Embolie pulmonaire
Thrombose veineuse
Lésions tissulaires
Gangrène
Facteurs de risque
5
Cholestérol LDL
Maladies vasculaires
Inactivité physique
Maladies cardiovasculaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cellules endothéliales : Questions médicales les plus fréquentes",
"headline": "Cellules endothéliales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cellules endothéliales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cellules endothéliales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellules épithéliales",
"url": "https://questionsmedicales.fr/mesh/D004847",
"about": {
"@type": "MedicalCondition",
"name": "Cellules épithéliales",
"code": {
"@type": "MedicalCode",
"code": "D004847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Progéniteurs endothéliaux",
"alternateName": "Endothelial Progenitor Cells",
"url": "https://questionsmedicales.fr/mesh/D066026",
"about": {
"@type": "MedicalCondition",
"name": "Progéniteurs endothéliaux",
"code": {
"@type": "MedicalCode",
"code": "D066026",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436.275.182"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cellules endothéliales de la veine ombilicale humaine",
"alternateName": "Human Umbilical Vein Endothelial Cells",
"url": "https://questionsmedicales.fr/mesh/D061307",
"about": {
"@type": "MedicalCondition",
"name": "Cellules endothéliales de la veine ombilicale humaine",
"code": {
"@type": "MedicalCode",
"code": "D061307",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436.275.682"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Podosomes",
"alternateName": "Podosomes",
"url": "https://questionsmedicales.fr/mesh/D000069261",
"about": {
"@type": "MedicalCondition",
"name": "Podosomes",
"code": {
"@type": "MedicalCode",
"code": "D000069261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436.275.841"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cellules endothéliales",
"alternateName": "Endothelial Cells",
"code": {
"@type": "MedicalCode",
"code": "D042783",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter Carmeliet",
"url": "https://questionsmedicales.fr/author/Peter%20Carmeliet",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be."
}
},
{
"@type": "Person",
"name": "Kim D Falkenberg",
"url": "https://questionsmedicales.fr/author/Kim%20D%20Falkenberg",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Katerina Rohlenova",
"url": "https://questionsmedicales.fr/author/Katerina%20Rohlenova",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Yonglun Luo",
"url": "https://questionsmedicales.fr/author/Yonglun%20Luo",
"affiliation": {
"@type": "Organization",
"name": "Lars Bolund Institute of Regenerative Medicine, BGI-Qindao, Qindao, China."
}
},
{
"@type": "Person",
"name": "Walter Muranyi",
"url": "https://questionsmedicales.fr/author/Walter%20Muranyi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Advances in pharmacotherapies for hyperuricemia.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/36999206",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14656566.2023.2197591"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of High-Altitude Polycythemia and Hyperuricemia and Risk Factors for Hyperuricemia in High-Altitude Immigrants.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37015076",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/ham.2022.0133"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exercise and hyperuricemia: an opinion article.",
"datePublished": "2024-08-26",
"url": "https://questionsmedicales.fr/article/39183708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07853890.2024.2396075"
}
},
{
"@type": "ScholarlyArticle",
"name": "Susceptibility genes of hyperuricemia and gout.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35922835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41065-022-00243-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperuricemia is accompanied by elevated peripheral CD4",
"datePublished": "2023-08-02",
"url": "https://questionsmedicales.fr/article/37532790",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-39775-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cellules épithéliales",
"item": "https://questionsmedicales.fr/mesh/D004847"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cellules endothéliales",
"item": "https://questionsmedicales.fr/mesh/D042783"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cellules endothéliales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cellules endothéliales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cellules endothéliales",
"description": "Comment diagnostiquer une dysfonction endothéliale ?\nQuels examens pour évaluer les cellules endothéliales ?\nQuels marqueurs biologiques indiquent une inflammation endothéliale ?\nComment évaluer la perméabilité endothéliale ?\nQuels tests pour détecter des lésions endothéliales ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Hyperuricemia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cellules endothéliales",
"description": "Quels symptômes indiquent une dysfonction endothéliale ?\nComment reconnaître une inflammation endothéliale ?\nQuels signes cliniques d'athérosclérose ?\nQuels symptômes d'une thrombose veineuse ?\nComment se manifeste une ischémie ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Hyperuricemia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cellules endothéliales",
"description": "Comment prévenir la dysfonction endothéliale ?\nQuelles habitudes pour réduire l'inflammation ?\nComment prévenir l'athérosclérose ?\nQuelles mesures pour éviter la thrombose ?\nComment réduire le risque d'ischémie ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Hyperuricemia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cellules endothéliales",
"description": "Quels traitements pour la dysfonction endothéliale ?\nComment traiter l'inflammation endothéliale ?\nQuelles interventions pour l'athérosclérose ?\nQuels médicaments pour prévenir la thrombose ?\nComment gérer l'ischémie chronique ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Hyperuricemia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cellules endothéliales",
"description": "Quelles complications de la dysfonction endothéliale ?\nQuels risques liés à l'inflammation endothéliale ?\nQuelles complications de l'athérosclérose ?\nQuels dangers d'une thrombose veineuse ?\nQuelles complications de l'ischémie ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Hyperuricemia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cellules endothéliales",
"description": "Quels facteurs de risque pour la dysfonction endothéliale ?\nComment le stress influence-t-il l'endothélium ?\nQuels rôles du cholestérol dans la santé endothéliale ?\nComment l'alimentation affecte-t-elle l'endothélium ?\nQuels impacts de l'inactivité physique sur l'endothélium ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Hyperuricemia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction endothéliale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'échographie Doppler et les marqueurs sanguins peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer les cellules endothéliales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biopsies tissulaires et les analyses histologiques sont couramment pratiquées."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques indiquent une inflammation endothéliale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme la protéine C-réactive et les cytokines peuvent être mesurés."
}
},
{
"@type": "Question",
"name": "Comment évaluer la perméabilité endothéliale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de perméabilité utilisant des colorants ou des marqueurs radioactifs sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests pour détecter des lésions endothéliales ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie et l'imagerie par résonance magnétique peuvent révéler des lésions."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction endothéliale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des troubles circulatoires et des œdèmes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une inflammation endothéliale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur et gonflement au site affecté sont des signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques d'athérosclérose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs dans la poitrine, fatigue et essoufflement peuvent indiquer une athérosclérose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une thrombose veineuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gonflement, douleur et rougeur dans la zone touchée sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une ischémie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ischémie se manifeste par des douleurs, des engourdissements et une faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dysfonction endothéliale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel."
}
},
{
"@type": "Question",
"name": "Quelles habitudes pour réduire l'inflammation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, réduire le stress et consommer des aliments anti-inflammatoires aide."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'athérosclérose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Contrôler la pression artérielle, le cholestérol et pratiquer une activité physique régulière."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la thrombose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rester actif, s'hydrater et éviter de rester immobile longtemps sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'ischémie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gérer le diabète, contrôler le poids et éviter les aliments riches en graisses saturées."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dysfonction endothéliale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les statines et des changements de mode de vie sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter l'inflammation endothéliale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anti-inflammatoires et des corticostéroïdes peuvent être prescrits selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles interventions pour l'athérosclérose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des procédures comme l'angioplastie ou le pontage peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour prévenir la thrombose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants et les antiplaquettaires sont souvent utilisés pour prévenir la thrombose."
}
},
{
"@type": "Question",
"name": "Comment gérer l'ischémie chronique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements médicaux, des exercices et parfois une chirurgie sont envisagés."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dysfonction endothéliale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des maladies cardiovasculaires, des AVC et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'inflammation endothéliale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation peut provoquer des thromboses, des embolies et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'athérosclérose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut mener à des crises cardiaques, des AVC et des douleurs angineuses."
}
},
{
"@type": "Question",
"name": "Quels dangers d'une thrombose veineuse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une thrombose peut provoquer une embolie pulmonaire, mettant en danger la vie."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'ischémie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ischémie peut entraîner des lésions tissulaires, des gangrènes et des amputations."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dysfonction endothéliale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension, le diabète, le tabagisme et l'obésité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il l'endothélium ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut aggraver l'inflammation et la dysfonction endothéliale."
}
},
{
"@type": "Question",
"name": "Quels rôles du cholestérol dans la santé endothéliale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de cholestérol LDL est un facteur de risque majeur pour les maladies vasculaires."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation affecte-t-elle l'endothélium ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en graisses saturées et en sucres peut nuire à la fonction endothéliale."
}
},
{
"@type": "Question",
"name": "Quels impacts de l'inactivité physique sur l'endothélium ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le manque d'exercice physique contribue à la dysfonction endothéliale et aux maladies cardiovasculaires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Lars Bolund Institute of Regenerative Medicine, BGI-Qindao, Qindao, China.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
BGI-Shenzhen, Shenzhen, China.
China National GeneBank, BGI-Shenzhen, Shenzhen, China.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany. christian.schwerk@medma.uni-heidelberg.de.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN.
Lions Gift of Sight Eye Bank, St. Paul, MN.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN.
Lions Gift of Sight Eye Bank, St. Paul, MN.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
1 publication dans cette catégorie
Affiliations :
University of California Merced, Graduate Program in Quantitative and Systems Biology, Merced, California, United States; slimbu@ucmerced.edu.
Publications dans "Cellules endothéliales" :
1 publication dans cette catégorie
Affiliations :
University of California Merced, School of Engineering, 5200 N Lake Rd, Merced, Merced, California, United States, 95343-5001; kmccloskey@ucmerced.edu.
Publications dans "Cellules endothéliales" :
Hyperuricemia is an overlooked cardiovascular and renal risk factor. Epidemiological and genetic studies have shown an independent role of uric acid in the risk of coronary artery disease, heart failu...
In the present review, we summarized current therapeutic indications and options for the treatment of symptomatic and asymptomatic hyperuricemia. Furthermore, we searched the recent literature (last 5...
Future large well-designed clinical trials on the role of hypouricemic agents in nephroprotection and cardiovascular prevention and treatment are warranted and may extend their indications and use, wi...
Song Zhen, Anxin Zhang, Jie Luo, Guanghai Xiong, Haibo Peng, Rang Zhou, Yuanfeng Li, Hongqiang Xu, Zhen Li, Wei Zhao, and Haoxiang Zhang. Prevalence of high-altitude polycythemia and hyperuricemia and...
Hyperuricaemia (HUA) is an abnormally high concentration of serum urate caused by either an excess of uric acid production or decreased excretion capacity in the body. Serum urate concentration forms ...
Gout is a chronic metabolic disease that seriously affects human health. It is also a major challenge facing the world, which has brought a heavy burden to patients and society. Hyperuricemia (HUA) is...
Hyperuricemia (HUA) makes a chronic inflammation status, which affects immune cells. The association between HUA and immune cells, such as monocytes and neutrophils, has been extensively studied. Howe...
Hyperuricemia is closely linked to obesity. As lifestyles and dietary patterns evolve, the prevalence of hyperuricemia has been on the rise. Bariatric surgery, an efficacious intervention for morbid o...
Pyrazinamide is one of the antitubercular drugs used for 2 months in the intensive phase. One of the adverse effects of pyrazinamide is hyperuricemia, with a symptom of arthralgia. This study aims to ...
It was an analytic observational study with a prospective cohort design. Three ml of blood from each pulmonary TB patient was withdrawn to examine uric acid levels before and after 2 months of treatme...
Twenty pulmonary TB patients met the inclusion criteria in this study. Eight out of 12 (60%) TB patients showed uric acid levels ≥7 mg/dl and 8 of them (66.6%) showed symptoms of arthralgia. The media...
Uric acid levels significantly increased during the intensive phase. Pulmonary TB patients with hyperuricemia are a risk factor for arthralgia....
The objective of the study was to explore the potential biomarkers and risk factors in children with immunoglobulin A nephropathy (IgAN)....
Untargeted metabolomics analysis was performed on children with IgAN before and after treatment. Subsequently, a retrospective study involving the past 15 years and a follow-up study were performed to...
Serum metabolomics analyses showed that levels of serum xanthosine were closely related to the outcome of IgAN, and KEGG analyses showed that differential metabolites were significantly enriched in pu...
We first performed a dynamic metabolomics study to reveal that hyperuricemia is closely related to the progression of IgAN in children. Then retrospective and follow-up studies confirmed that hyperuri...
We first performed a dynamic metabolomics study to reveal that hyperuricemia was closely related to the progression of IgAN in children. Retrospective analyses in past 15 years confirmed that IgAN chi...
Hyperuricemia and sarcopenia are both strongly linked to an increased risk of atherosclerotic cardiovascular disease (ASCVD), and this study was designed to look into the interactive effects of hyperu...
This study collected information from patients (N = 2647) who underwent health check-ups at the Health Care Building of Wuhan Union Hospital between January 2019 and December 2020. Skeletal muscle mas...
The prevalence of hyperuricemia and sarcopenia was 23.57% and 15.34%, respectively. The occurrence of cardiovascular risk factors such as obesity, hypertension, diabetes mellitus, chronic kidney disea...
Hyperuricemia is independently associated with high-risk ASCVD; Sarcopenia and high-risk ASCVD did not show an independent relationship, but there was a synergistic effect of the two on ASCVD risk, wh...
Hyperuricemia and gout are a group of disorders of purine metabolism. In recent years, the incidence of hyperuricemia and gout has been increasing, which is a severe threat to people's health. Several...
We used professional databases including PubMed, Web of Science to conduct the literature review. This review addresses the current landscape of hyperuricemia and gout biomarkers with a focus on prote...
Proteomic methods are used to identify differentially expressed proteins to find specific biomarkers. These findings may be suggestive for the diagnosis and treatment of hyperuricemia and gout to expl...
We suggest some possible relationships of potential biomarkers with inflammatory episodes, complement activation, and metabolic pathways. These biomarkers are able to distinguish between different sta...